GlaxoSmithKline shares fall 2.59%, among top losers on Nifty Midcap 150

Shares of GlaxoSmithKline were among the top losers on the Nifty Midcap 150, declining by 2.59%. The stock traded at Rs 2,667.40 at 10:30 am Friday's session. Other stocks that were among the top losers on the Nifty Midcap 150 were Biocon, Gland, Hind Zinc and Vodafone Idea.

GlaxoSmithKline Financial Overview

Here's a look at GlaxoSmithKline's key financial data:

Consolidated Quarterly Results

The following table presents the consolidated quarterly results for GlaxoSmithKline:
The revenue for the quarter ending June 2025 was Rs 805.17 Crore, a decrease compared to Rs 974.37 Crore in the quarter ending March 2025. Net profit for the same period was Rs 205.01 Crore, down from Rs 262.87 Crore in the previous quarter.

Consolidated Yearly Results

The following table presents the consolidated yearly results for GlaxoSmithKline:
The annual revenue increased from Rs 3,453.71 Crore in 2024 to Rs 3,749.21 Crore in 2025. Similarly, the net profit rose from Rs 589.96 Crore in 2024 to Rs 927.58 Crore in 2025.

Consolidated Yearly Income Statement

The following table presents the consolidated yearly income statement:

Consolidated Quarterly Income Statement

The following table presents the consolidated quarterly income statement:

Cash Flow

The following table shows the cash flow from various activities:

Balance Sheet

The following table shows the balance sheet data:

Financial Ratios

Key financial ratios for GlaxoSmithKline are provided in the table below:

GlaxoSmithKline Corporate Actions

Recent corporate actions by GlaxoSmithKline include:

• Announcement: Intimation regarding 100 days campaign - Saksham Niveshak on September 25, 2025.
• Disclosure: Disclosure under Regulation 30 on September 8, 2025.
• Press Release: Press release dated August 25, 2025, regarding foray into Oncology with Jemperli and Zejula.

Dividends declared by the company include a final dividend of Rs 42.00 per share (420%) with effective date of May 30, 2025 and an interim dividend of Rs 12.00 per share (120%) with effective date of November 7, 2024.

GlaxoSmithKline has issued bonus shares on multiple occasions, including a 1:1 bonus ratio on September 11, 2018, and a 1:1 bonus ratio on January 2, 1995. Additionally, a 1:3 bonus ratio was issued on June 23, 1980.

The company had rights issue with existing ratio of 5 and offered ratio of 1 on exrights date of May 21, 1993.

With the stock's last traded price at Rs 2,667.40, GlaxoSmithKline has seen a decrease in today's session and the stock is among the top losers on Nifty Midcap 150.